Chronic kidney disease trials in United States

In United States 224 Also abroad 814

224 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Where
Albuquerque, Aurora, Boston, Chicago, Dallas, Decatur, Durham, Gainesville, Iowa City, Long Beach, Minneapolis, Omaha, Philadelphia, Pittsburgh, Salisbury, Salt Lake City, Seattle, West Haven
Age
18 years and over
People
2,540
Run by
VA Office of Research and Development
See details and how to joinNCT05931276
No phaseEnrolling by invitation
ECHO for Diabetes and Multiple Chronic Conditions Study
Where
Santa Fe
Age
18 years to 89 years
People
20
Run by
University of New Mexico
See details and how to joinNCT06451458
Phase 4Enrolling by invitation
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Where
Temple
Age
18 years to 84 years
People
64
Run by
Baylor Research Institute
See details and how to joinNCT07547878
Phase 2Taking people
A Study of Luspatercept in People With Anemia
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
30
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07725497
No phaseTaking people
CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
Where
Chicago
Age
18 years and over
People
50
Run by
University of Illinois Chicago
See details and how to joinNCT07210710
Phase 1Taking people
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Where
Boston, New York, Philadelphia
Age
18 years to 65 years
People
20
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06056102
No phaseTaking people
Physical Activity in CKD
Where
Philadelphia
Age
13 years to 18 years
People
100
Run by
Children's Hospital of Philadelphia
See details and how to joinNCT06624358
No phaseEnrolling by invitation
Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission
Where
Boston
Age
18 years and over
People
400
Run by
Massachusetts General Hospital
See details and how to joinNCT07866872
Phase 1/2Not yet taking people in United States
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Where
Chula Vista, Lakeland, Statesville, Wilmington
Age
18 years to 75 years
People
94 worldwide
Run by
Ingenia Therapeutics INC
See details and how to joinNCT07231679
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Aurora, Baltimore, Boston, Chubbuck, Dallas, Glendale, Hinsdale, Houston, Jersey City, Kansas City, Las Vegas, Newark, New York, Rochester, San Diego, San Dimas
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
No phaseTaking people
The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
Where
Portland
Age
18 years to 80 years
People
1,500
Run by
Kaiser Permanente
See details and how to joinNCT07857200
No phaseTaking people
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
Where
Boston
Age
18 years to 85 years
People
50
Run by
Boston Medical Center
See details and how to joinNCT04399941
Phase 1/2Taking people
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Where
Buffalo, Houston, Orange, Palo Alto, San Francisco, St Louis
Age
18 years and over
People
75 worldwide
Run by
Oncorena AB
See details and how to joinNCT05287945
No phaseTaking people
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Where
Ann Arbor, Birmingham, Duluth, Durham, Houston, St. Petersburg, Temple
Age
18 years and over
People
500
Run by
Duke University
See details and how to joinNCT06906627
No phaseTaking people
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Where
Ann Arbor, Birmingham, Duluth, Durham, Houston, St. Petersburg, Temple
Age
18 years and over
People
212
Run by
Duke University
See details and how to joinNCT06906640
Phase 1Taking people
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
Where
Chandler, Miami Lakes, Orlando
Age
18 years to 84 years
People
30
Run by
Bristol-Myers Squibb
See details and how to joinNCT07763418
Phase 1Taking people
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Where
Orlando, San Antonio
Age
18 years to 85 years
People
32
Run by
Kailera
See details and how to joinNCT07793929
No phaseTaking people
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Where
Baltimore, Chicago, Los Angeles, Minneapolis, New Haven, New York, Orange, Philadelphia, San Francisco
Age
18 years to 70 years
People
20
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT05106387
Early phase 1Taking people
Concomitant Renal and Urinary Bladder Allograft Transplantation
Where
Rochester
Age
1 year to 60 years
People
30
Run by
Mayo Clinic
See details and how to joinNCT04626167
Phase 3Withdrawn
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Atlanta, Baltimore, Boston, Cincinnati, Cleveland, Hollywood, Iowa City, Kansas City, Los Angeles, Palo Alto, Philadelphia, Phoenix, Portland, Salt Lake City, San Antonio, San Diego, Seattle, Washington D.C.
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Albany, Albuquerque, Ann Arbor, Arlington, Asheville, Boca Raton, Brunswick, Charlotte, Chattanooga, Cincinnati, Columbia, Concord, Daly City, East Point, Fort Lauderdale, Fort Worth, Fremont, Gainesville, Greenville, Hollywood, Houston, Huntington Park, Huntsville, Iowa City, Irving, Jacksonville Beach, Kansas City, Lakeland, Lancaster, Little Rock, Long Island City, Louisville, Lufkin, Lynwood, Macon, Mankato, McKinney, Media, Melbourne, Northridge, Oak Brook, Orlando, Palo Alto, Pasadena, Pomona, Port Charlotte, Richmond, Riverside, Riverview, Rockford, Saint Joseph, Salem, San Antonio, San Dimas, Savannah, Sherman, Stephenville, Sugar Land, Surprise, Tarzana, Tempe, The Bronx, Washington D.C., Weston, Wichita, Woodbridge
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
No phaseTaking people
Lifestyle Intervention In CKD
Where
Durham
Age
18 years and over
People
152
Run by
Duke University
See details and how to joinNCT07633145
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Albany, Arvada, Austin, Bakersfield, Baton Rouge, Beaumont, Bethlehem, Beverly Hills, Bloomfield, Bluefield, Boca Raton, Boston, Bradenton, Brookhaven, Brooklyn, Brooksville, Brunswick, Charlotte, Chattanooga, Chesapeake, Chula Vista, College Point, Columbia, Columbus, Coral Gables, Coral Springs, Cordele, Dallas, Decatur, Denver, Douglasville, Durham, East Providence, Eatontown, El Paso, Exton, Fairfax, Fort Wayne, Fort Worth, Fresno, Fullerton, Gallup, Garden Grove, Glendale, Granada Hills, Greenville, Hampton, Henderson, Hialeah Gardens, Hollywood, Houston, Huntsville, Jersey City, Kalamazoo, Kansas City, Kinston, Knoxville, La Jolla, La Mesa, La Palma, Laredo, Las Vegas, Lauderdale Lakes, Lawrenceville, Lincoln, Los Angeles, Louisville, Lynwood, Mansfield, McAllen, Medley, Memphis, Miami, Miami Lakes, Middlebury, Mineola, Minneapolis, Mishawaka, Montgomery, Nashville, Newark, Norfolk, North Platte, Northridge, Orlando, Oxnard, Phoenix, Pomona, Pontiac, Portsmouth, Raleigh, Reno, Richmond, Riverside, Roseville, Saint Clair Shores, Salinas, San Antonio, San Diego, San Dimas, Sanford, San Jose, Shelby, Shenandoah, Sherman, Sioux City, Spartanburg, Statesboro, Tampa, Tarzana, Temple Terrace, The Bronx, The Woodlands, Tucson, Tupelo, Vacaville, Victorville, Wichita, Winter Park
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
No phaseTaking people
Improving the Collaborative Health of Adult Dyads
Where
Columbia
Age
18 years and over
People
500
Run by
University of South Carolina
See details and how to joinNCT05370014
No phaseEnrolling by invitation
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
Where
Meridian
Age
30 years to 80 years
People
50
Run by
Prokidney
See details and how to joinNCT06790498